OR WAIT null SECS
October 07, 2019
When the injector design is finalized, Stevanato Group will produce it at one of its manufacturing facilities using extensive tooling, molding, and assembly expertise.
October 04, 2019
GSK invested $139 million to its Rockville, MD site to support demand for Benlysta.
The companies are working together with Japanese clients to outline projects from early clinical stage up to commercial launch.
The new joint venture, named Oerth Bio, will use Arvinas’ Protac technology to develop innovative new agricultural products. As part of its collaboration with Arvinas, Bayer is also using this technology to develop human therapeutics.
October 03, 2019
Manufacturing of the cell line will take place at Lonza’s GMP facility in Geleen, Netherlands.
October 01, 2019
New therapies, new technologies, global supply chain challenges, and political pressures draw pharma professionals to major industry event.
September 27, 2019
Nanoform and AstraZeneca have agreed to start a technology evaluation of Nanoform’s CESS Technology across a range of AstraZeneca’s pharmaceutical products.
The companies plan to collaborate for the advancement of an optical system for on-line analysis of mammalian cells during a bioprocess.
The initiative looks to improve treatments for chronic pain, curb the rates of opioid use disorder (OUD) and overdose, and achieve long-term recovery from opioid addiction.
September 26, 2019
If clinical trials are successful, roluperidone (MIN-101) will be the first treatment approved to treat symptoms of schizophrenia in the United States.